Related references
Note: Only part of the references are listed.Immune-Mediated Myocarditis in Fabry Disease Cardiomyopathy
Andrea Frustaci et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Paradoxical Response to Enzyme Replacement Therapy of Fabry Disease Cardiomyopathy
Andrea Frustaci et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2016)
Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy
Cristina Chimenti et al.
HUMAN PATHOLOGY (2015)
Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease.
CM Eng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
